Shares of SciSparc Ltd. (NASDAQ:SPRC – Get Free Report) were down 3.8% during mid-day trading on Friday . The company traded as low as $0.31 and last traded at $0.33. Approximately 202,624 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 3,741,648 shares. The stock had previously closed at $0.34.
SciSparc Stock Performance
The business’s 50 day simple moving average is $0.47 and its 200-day simple moving average is $0.35.
About SciSparc
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.
See Also
- Five stocks we like better than SciSparc
- How to Plot Fibonacci Price Inflection Levels
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Options Trading – Understanding Strike Price
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- What is a Bond Market Holiday? How to Invest and Trade
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for SciSparc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciSparc and related companies with MarketBeat.com's FREE daily email newsletter.
